1.
Bragagni M, Mennini N, Ghelardini C, Mura P. Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain Targeting. J Pharm Pharm Sci [Internet]. 2012 Feb. 10 [cited 2024 Apr. 24];15(1):184-96. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/12370